Equity Overview
Price & Market Data
Price: $2.48
Daily Change: -$0.05 / 2.02%
Range: $2.44 - $2.54
Market Cap: $1,969,652
Volume: 48,139
Performance Metrics
1 Week: -8.86%
1 Month: -58.64%
3 Months: -83.76%
6 Months: -98.18%
1 Year: -99.94%
YTD: -97.61%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.